PubMed:32560744 / 3864-4228
Annnotations
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T26 | 109-110 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T27 | 124-125 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T28 | 346-347 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T34 | 0-364 | Sentence | denotes | However simulations have shown that around 16 participants are necessary to determine futility or promise of a candidate at a given dose (in efficacy evaluation alone) and between 32 and 40 participants are required across the dose-finding and efficacy evaluation when capping the maximum number of participants contributing to the evaluation of a treatment at 40. |